Development of a recombinant truncated nucleocapsid protein based immunoassay for detection of antibodies against human coronavirus OC43

Journal of Virological Methods

Volumn 177, Issue 1, 2011, Pages 100-106

  Blanchard, Elisabeth G ^a   Miao, Congrong ^a   Haupt, Thomas E ^b   Anderson, Larry J ^c   Haynes, Lia M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b WISCONSIN DIVISION OF PUBLIC HEALTH   (United States)

^c Emory Children's Center   (United States)

Author keywords

Coronavirus; HCoV OC43; Immunoassay; Nucleocapsid; Serology

Indexed keywords

RECOMBINANT PROTEIN; RECOMBINANT TRUNCATED NUCLEOCAPSID PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CORONAVIRUS; CORONAVIRUS INFECTION; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SERODIAGNOSIS; SERUM; VIRAL RESPIRATORY TRACT INFECTION; VIRUS DIAGNOSIS;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CORONAVIRUS INFECTIONS; CORONAVIRUS OC43, HUMAN; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MICE; NUCLEOCAPSID PROTEINS; RECOMBINANT PROTEINS; REFERENCE VALUES; SEQUENCE HOMOLOGY, AMINO ACID; SEROEPIDEMIOLOGIC STUDIES;

CORONAVIRUS;

EID: 84860397848     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.07.005     Document Type: Article

References (23)

1. Arbour N., Day R., Newcombe J., Talbot P.J. Neuroinvasion by human respiratory coronaviruses. J. Virol. 2000, 74:8913-8921.
2. Birch C.J., Clothier H.J., Seccull A., Tran T., Catton M.C., Lambert S.B., Druce J.D. Human coronavirus OC43 causes influenza-like illness in residents and staff of aged-card facilities in Melbourne, Australia. Epidemiol. Infect. 2005, 133:273-277.
3. Chan C.M., Tse H., Wong S.S.Y., Woo P.C.Y., Lau S.K.P., Chen L., Zheng B.J., Huang J.D., Yuen K.Y. Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus. J. Clin. Virol. 2009, 45:54-60.
4. El-Sahly H.M., Atmar R.L., Glezen W.P., Greenberg S.B. Spectrum of clinical illness in hospitalized patients with 'common cold' virus infections. Clin. Infect. Dis. 2000, 31:96-100.
5. Falsey A.R., Walsh E.E., Hayden F.G. Rhinovirus and coronavirus infection-associated hospitalizations among older adults. J. Infect. Dis. 2002, 185:1338-1341.
6. Glezen W.P., Greenberg S.B., Atmar R.L., Piedra P.A., Couch R.B. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 2000, 283:499-505.
7. Greiner M. Two-graph receiver operating characteristic (TG-ROC): a Microsoft-EXCEL template for the selection of cut-off values in diagnostic tests. J. Immunol. Methods 1995, 185:145-146.
8. Greiner M., Sohr D., Göbel P. A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests. J. Immunol. Methods 1995, 185:123-132.
9. Hamre D., Kindig D.A., Mann J. Growth and intracellular development of a new respiratory virus. J. Virol. 1967, 1:810-816.
10. Haynes L.M., Miao C., Harcourt J.L., Montgomery J.M., Le M.Q., Dryga S.A., Kamrud K.I., Rivers B., Babcock G.J., Oliver J.B., Comer J.A., Reynolds M., Uyeki T.M., Bausch D., Ksiazek T., Thomas W., Alterson H., Smith J., Ambrosino D.M., Anderson L.J. Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins. Clin. Vaccine Immunol. 2007, 14:331-333.
11. Larson H.E., Reed S.E., Tyrell D.A. Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J. Med. Virol. 1980, 5:221-229.
12. Lehmann C., Wolf H., Xu J., Zhao Q., Shao Y., Motz M., Lindner P. A line immunoassay utilizing recombinant nucleocapsid proteins for detection of antibodies to human coronaviruses. Diagn. Microbiol. Infect. Dis. 2008, 61:40-48.
13. McIntosh K., Chao R.K., Krause H.E., Wasil R., Mocega H.E., Mufson M.A. Coronavirus infection in acute lower respiratory tract disease of infants. J. Infect. Dis. 1974, 130:502-507.
14. Mourez T., Vabret A., Han Y., Dina J., Legrand L., Corbet S., Freymuth F. Baculovirus expression of HCoV-OC43 nucleocapsid protein and development of a Western blot assay for detection of human antibodies against HCoV-OC43. J. Virol. Methods 2007, 139:175-180.
15. Patrick D.M., Petric M., Skowronski D.M., Guasparini R., Booth T.F., Krajden M., McGeer P., Bastien N., Gustafson L., Dubord J., Macdonald D., David S.T., Srour L.F., Parker R., Andonov A., Isaac-Renton J., Loewen N., McNabb G., McNabb A., Goh S.H., Henwick S., Astell C., Guo J.P., Drebot M., Tellier R., Plummer F., Brunham R.C. An outbreak of human coronavirus OC43 infection and serological cross-reactivity with SARS coronavirus. Can J. Infect. Dis. Med. Microbiol. 2006, 17:330-336.
16. Severance E.G., Bossis I., Dickerson F.B., Stallings C.R., Origoni A.E., Sullens A., Yolken R.H., Viscidi R.P. Development of a nucleocapsid-based human coronavirus immunoassay and estimates of individuals exposed to coronavirus in a U.S. metropolitan population. Clin. Vaccine Immunol. 2008, 15:1805-1810.
17. Sun Z.F., Meng X.J. Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group 1 animal coronaviruses:implication for SARS diagnosis. J. Clin. Microbiol. 2004, 42:2351-2352.
18. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P., Peñaranda S., Bankamp B., Maher K., Chen M.-h., Tong S., Tamin A., Lowe L., Frace M., DeRisi J.L., Chen Q., Wang D., Erdman D.D., Peret T.C.T., Burns C., Ksiazek T.G., Rollin P.E., Sanchez A., Liffick S., Holloway B., Limor J., McCaustland K., Olsen-Rasmussen M., Fouchier R., Günther S., Osterhaus A.D.M.E., Drosten C., Pallansch M.A., Anderson L.J., Bellini W.J. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003, 300:1394-1399.
19. van der Hoek L., Pyrc K., Jebbink M.F., Vermeulen-Oost W., Berkhout R.J.M., Wolthers K.C., Wertheim-van Dillen P.M.E., Kaandorp J., Spaargaren J., Berkhout B. Identification of a new human coronavirus. Nat. Med. 2004, 10:368-373.
20. Wege H., Siddell S., ter Meulen V. The biology and pathogenesis of coronaviruses. Curr. Top. Microbiol. Immunol. 1982, 99:165-200.
21. Woo P.C.Y., Lau S.K.P., Chu C.-m., Chan K.-h., Tsoi H.-w., Huang Y., Wong B.H.L., Poon R.W.S., Cai J.J., Luk W.-k., Poon L.L.M., Wong S.S.Y., Guan Y., Peiris J.S.M., Yuen K.-y. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with Pneumonia. J. Virol. 2005, 79:884-895.
22. Woo P.C.Y., Lau S.K.P., Huang Y., Yuen K.-Y. Coronavirus diversity, phylogeny and interspecies jumping. Exp. Biol. Med. 2009, 234:1117-1127.
23. Woo P.C., Lau S.K., Wong B.H., Chan K.H., Hui W.T., Kwan G.S., Peiris J.S., Couch R.B., Yuen K.Y. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E recitified by Western blotting with recombinant SARS-CoV spike polypeptide. J. Clin. Microbiol. 2004, 42:5885-5888.